ArticleJournal of attention disorders2025
"Everything's a Challenge": An Interview Study of ADHD Individuals in the Midst of the Prescription Stimulant Shortage.
Article in Journal of attention disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- University Students and the Stimulant Shortage: A Survey of Strategies to Obtain Medication, Consequences of Shortages, and Mental Health Correlates.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2026Article
- First-generation antipsychotic shortages in the United States: Utilization and switching patterns.Exploratory research in clinical and social pharmacy · 2026Article
- Generics in Medicaid increased in price and shifted to larger manufacturers amid 2022-2023 amphetamine shortage.Health affairs scholar · 2026Article
- Maintained Symptom Control Following a Shortage-Driven Switch to Immediate-Release Dextroamphetamine: A Case Report.Cureus · 2026Article
- Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey.Drug and alcohol review · 2026Article
- Stability in attention-deficit hyperactivity disorder prevalence: wishful illusion or complex reality?BJPsych open · 2026Article
- Stimulant shortage in children with ADHD: greater vulnerability among those with comorbidity.BMC psychiatry · 2026Article
- Content Analysis of the Portrayal of Prescription Stimulants on TikTok.Journal of attention disorders · 2025Article
- Attention-deficit hyperactivity disorder medication shortage in the United States: a qualitative assessment of Reddit posts.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe shortage of prescription stimulants is an ongoing issue that is impacting the ability of individuals with ADHD to access their medication. Amidst concerns that this shortage may have a substantial impact on individuals' ability to manage their symptoms effectively, this research seeks to understand the experiences and consequences for those affected.
methodsIn this study, we interviewed individuals with ADHD who have been directly impacted by the stimulant shortage. Thematic analysis focused on identifying common themes related to challenges with medication access and the resulting effects on daily living.
resultsThe study uncovered significant difficulties in accessing ADHD medication due to current shortages, leading to disruptions in the management of ADHD symptoms and subsequent detriments to individuals' professional, educational, and personal lives. Systematic controls aimed at reducing non-medical use were found to exacerbate these access issues, inadvertently compounding the challenges faced by those using medication for legitimate medical needs. Individuals also described ways they coped with the shortage, with some seeking ADHD medication via unofficial channels.
conclusionOur findings highlight the urgency of addressing stimulant shortages to safeguard the wellbeing of individuals with ADHD. This study also calls for a critical review of policy measures regulating stimulant medication access, and their effectiveness at reducing non-medical use given the unintended consequences these regulations appear to have on individuals prescribed these medications for therapeutic purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.